<DOC>
	<DOCNO>NCT01658384</DOCNO>
	<brief_summary>This study design evaluate effect Tysabri cognition multiple sclerosis ( MS ) patient . During period 24 month , study assess evolution cognitive function Tysabri treat MS patient use Symbol Digit Modalities Test ( SDMT ) CogState battery test .</brief_summary>
	<brief_title>Cognitive Evolution Tysabri Treated Multiple Sclerosis Patients</brief_title>
	<detailed_description>Tysabri reduce relapse frequency , slow progression preserve cognitive function compare placebo per AFFIRM trial . The benefit relapse rate progression appear sustain longer-term study STRATA . In clinical practice however despite stable condition Expanded Disability Status Scale ( EDSS ) patient often complain cognitive deterioration . It yet show Tysabri prevent cognitive deterioration 2 year treatment . The Symbol Digit Modalities Test ( SDMT ) sensitive validate test cognition MS. CogState offer standardized battery cognitive test frequently use clinical research field dementia Parkinson 's disease . The CogState battery test consist Detection test ( process speed ) , Identification test ( attention ) , One Back test ( work memory ) , International Shopping List test ( verbal learning ) Groton Maze Learning test ( reason problem solve ) confirm validate result Symbol Digit Modalities Test ( SDMT ) MS patient well examine cognitive parameter . Together test do prospectively assess evolution cognitive function Tysabri treat MS patient long term .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Natalizumab</mesh_term>
	<criteria>Patients multiple sclerosis receive Tysabri per indication willing able give inform consent . Patients depress per Beck depression questionnaire screening time study . Patients cognitive decline cause MS .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>